Allied Market Research

Biobanking Market Expected to Reach $69.52 Billion by 2028-Allied Market Research


Report Code : A02463

quote The growth of the global biobanking market is attributed to increase in incidence of chronic disease such as cancer bolsters the market of biobanking. Since the use of conventional therapies have serious side-effects, integrating it with stem cell therapy reduces the damage and hence the increased demand. quote

Onkar Sumant
Manager, Healthcare at Allied Market Research

Get 20% Free Customization In This Report
Follow us on Social Media:       

According to a new report published by Allied Market Research, titled, "Biobanking Market by Specimen Type, Type of Biobank, Ownership, Application and End User: Global Opportunity Analysis and Industry Forecast, 2021–2028," the global biobanking market was valued at $42.10 billion in 2020, and is estimated to reach $69.52 billion by 2028, growing at a CAGR of 6.2% from 2021 to 2028. 

Biobanking is a biorepository for receiving and storing biological specimens such as plant, animal, and microbe; which can be later used for supporting many types of contemporary research associated with genomics, healthcare research, medical care, and drug discovery. In addition, biobanking permits large-scale analysis for individuation of specific disease biomarkers, which will facilitate the development of personalized medicine. For promoting the health and well-being of the community, the need for proactive participation is necessary for medical institutions, especially community medical centers. Furthermore, several types of biobanks are currently established to support medical research, such as population biobanks and disease-oriented biobanks. 

The biobanking market is positively impacted by the pandemic. Furthermore, COVID-19 has brought to light the importance of biobanking and its role in understanding disease patterns and its utility in developing vaccines and other prevention and treatment protocols. Furthermore, the government is now focusing on biobanks and repositories worldwide, in which regulators will support this endeavor by working on easing approvals. For instance, the Indian Council of Medical Research (ICMR) has notified 16 bio-repositories to collect, store, and maintain clinical samples, including oropharyngeal/nasopharyngeal swabs, broncheoalveolar lavage , sputum, blood, urine, and stool of COVID-19 patients. The samples from COVID-19 patients will be collected and archived for future use to develop validated diagnostics, therapeutics, and vaccines. Furthermore, the market is expected to continue to grow post the pandemic.

Several organizations are participating to create written biobanking guidelines such as the World Medical Association, Council for International Organizations of Medical Sciences, Council of Europe, Human Genome Organization, World Health Organization, and United Nations Educational, Scientific and Cultural Organization (UNESCO).

The major factors that contribute toward the market growth include a rise in funding by private & government organizations to biobanking and increase in application areas of bio banked samples. Bio banked specimens are used in the treatment of several chronic diseases, and thus increase in incidence of disease such as cancer further supports the market growth. However, ethical issues related to biobanking and lack of awareness about it are expected to impede the market growth. Conversely, unmet medical needs in emerging nations are expected to provide a lucrative opportunity in the market.

On the basis of specimen type, the global biobanking market is divided into the blood products, solid tissue, cell lines, nucleic acid, and others. The blood product segment was the major revenue contributor in 2020, and is anticipated to remain dominant during the forecast period. This is attributed to surge in the prevalence of hematological diseases and a rise in number of accidents. By application, the global biobanking market is bifurcated into therapeutic and research. The research segment dominated the market in 2020, and is anticipated to continue this trend during the forecast period. This is attributed to increase in incidence of chronic diseases and advancements in regenerative medicines. 

Depending on ownership, the global biobanking market is segregated into a national/regional agency, non-profit organization, universities, and private organization. The national/regional agency segment led the market in 2020, and is anticipated to maintain its lead during the forecast period. This is attributed to the expansion of private & governmental biobanking organizations and the rise in genomic & proteomics research to study and identify genomic variations for rare diseases.

According to the type of biobank, the market is bifurcated into population-based biobank and disease-oriented biobank. The disease-oriented biobank segment was the major revenue contributor in 2020, and is anticipated to continue this trend during the forecast period. This is attributed to increase in the geriatric population and rise in awareness & adoption of biobanking products for treatment of chronic diseases. By end user, the market is classified into academic institution and pharma & biotech companies. This is attributed to increase in prevalence of blood transfusion disease, development in healthcare sector, and advancement in R&D. Region wise, 

North America was the largest shareholder in the global biobanking market in 2020, owing to its well-established healthcare infrastructure, the surge in adoption of cell & stem therapy, increase in the geriatric population, and a rise in prevalence of chronic diseases. However, Asia-Pacific is anticipated to register the highest CAGR during the forecast period, owing to increase in health awareness, development in health care infrastructure, and rise in the number of hospitals equipped with advanced medical facilities. 

Key Findings Of The Study 

  • By specimen type, the blood products segment was the highest contributor to the market in 2020.
  • By type of biobank, the disease oriented biobank was the highest contributor to the market in 2020.
  • By ownership, the private organization segment is projected to grow at a significant CAGR of 9.10% from 2021 to 2028.
  • By application, the research segment contributed for nearly 6.70% of the global biobanking market in 2020.
  • By end user, the pharma and biotech segment dominated the market in 2020 and is expected to continue this trend throughout the review period.
  • By region, North America garnered largest revenue share in 2020, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the review period.

Need More Information

pr-det-talk Talk to David (Europe)

pr-det-talk Talk to Sona Padman (Americas)

5933 NE Win Sivers Drive #205,
Portland, OR 97220 United States

pr-det-phone Toll Free: +1-800-792-5285

pr-det-phone UK: +44-845-528-1300

pr-det-phone Hong Kong: +852-301-84916

pr-det-phone India (Pune): +91 2066346060

pr-det-phone Fax: +1(855) 550-5975



For Media Inquiries, Please Contact

Tushar Nagose
Communications Officer
Allied Market Research
Contact Toll Free: +1-800-792-5285
Drop us an email at


First time buyer?
Check offers and discount on this report
To get this report

Click Here

quote Biobanking Market by Specimen Type (Blood Products, Solid Tissue, Cell Lines, Nucleic Acid, and Others), by Type of Biobank (Population-based Biobanks, and Disease-oriented Biobanks), By Ownership (National/regional agency, Non-profit Organization, Universities, and Private Organization), by Application (Therapeutics, and Research) and End User (Academic Institutes, and Pharma & Biotech Companies): Global Opportunity Analysis and Industry Forecast, 2021–2028 quote

View Report
Avenue Video Loading...

Avenue: Entire Library membership of Allied Market Research Reports at your disposal

  • Avenue is an innovative subscription-based online report database.
  • Avail an online access to the entire library of syndicated reports on more than 3,890 niche industries and company profiles on more than 12,953 firms across 11 domains.
  • A cost-effective model tailored for entrepreneurs, investors, and students & researchers at universities.
  • Request customizations, suggest new reports, and avail analyst support as per your requirements.
  • Get an access to the library of reports at any time from any device and anywhere.


Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs

Targeted Market View

Targeted market view to provide pertinent information and save time of readers


Featured Readings


Published Date Jan 2021

Surgical Equipment Market

Download Sample

Published Date Nov 2020

Medical Implant Market

Download Sample

Get Fresh content delivered

Get insights on topics that matter to your business. Stay updated on the area that interests you.

Get Industry Data Alerts

Buy Full Version
"Biobanking Market"
Purchase Enquiry